Learn how organizations can cross the GenAI divide by prioritizing the right use cases, aligning AI with business goals, and avoiding wasted investment.
Why GenAI Investment Rarely Translates into Results
Organizations continue to invest heavily in generative AI, yet measurable business impact remains elusive for most enterprises. The challenge is not awareness, experimentation, or access to tools. The challenge is execution.
In Communications of the ACM, Andreas Welsch highlights a recurring pattern across industries. Companies generate extensive lists of GenAI use cases but struggle to determine which initiatives deserve sustained investment. This disconnect explains why many organizations remain on the wrong side of the GenAI divide, defined as the gap between deploying AI technologies and achieving real business outcomes.
The Core Challenge: Too Many Use Cases, Too Little Prioritization
Most enterprises already have more GenAI ideas than they can realistically execute. Ideation workshops and internal submissions often produce hundreds of potential use cases across functions. The difficult question is not whether ideas exist, but which of them matter. “If you have 700 use cases, which are the top ones that you should implement?” This question exposes a leadership challenge. Without structured prioritization, organizations spread effort across too many initiatives. Resources are diluted, teams lose focus, and results fail to materialize.
Why Prioritization Determines GenAI Success
Effective prioritization requires a combination of technical understanding and business fluency. Decision-makers must assess whether a use case can influence meaningful outcomes, not just demonstrate technical feasibility. Professionals who understand both the technology and the business problem provide disproportionate value. Their ability to connect capabilities with outcomes enables organizations to concentrate investment where it matters most.
Applying GenAI in a Business Context
GenAI delivers value only when applied to specific business problems. Experiments that remain disconnected from operational goals rarely scale. “Technology needs to be applied in a business context,” shares Welsch. This insight explains why many GenAI initiatives stall after early pilots. Teams often focus on what a model can do rather than how it contributes to defined objectives.
Translating Capabilities Into Outcomes
High-performing organizations invest in translation. This means converting business challenges into solvable technical problems and defining success in measurable terms. When this translation is absent, GenAI initiatives lack direction and accountability.
The Risk of Continuing Underperforming GenAI Projects
Another recurring issue is persistence without performance. When GenAI projects fail to meet expectations, organizations frequently continue funding them in anticipation of future improvements. This pattern carries significant financial risk. Welsch explains: “You end up throwing good money after bad.” The difficulty lies in decision-making rather than technology. Stopping a project requires clarity on objectives, agreement on success criteria, and organizational willingness to acknowledge when results fall short.
Cultural and Organizational Barriers
Many leaders struggle to discontinue GenAI initiatives due to misaligned incentives or unclear ownership. Without strong alignment between business stakeholders and technically fluent teams, projects continue despite limited returns.
Mapping Organizational Pain Points to GenAI Capabilities
GenAI adoption improves when organizations clearly articulate what problem they are trying to solve. Success depends on mapping pain points to realistic capabilities. “The value lies in translating the organizational pain point into how technology can help solve for that pain point,” shares Welsch. This mapping process requires collaboration. Business stakeholders define the problem, while AI-literate teams assess how GenAI capabilities, such as summarization, analysis, and transformation, may contribute. When this collaboration is effective, GenAI becomes a targeted tool rather than a generalized experiment.
Collaboration as a Prerequisite for Impact
GenAI initiatives perform best when business and technology teams work closely together from the outset. Welsch summarizes: “There is a need for a more technology, AI-savvy team to collaborate with the business team.” Shared understanding reduces misalignment and ensures that GenAI investments remain tied to operational needs. Collaboration also enables earlier course correction when initiatives fail to meet expectations.
Conclusion: Focus Enables GenAI Value
Crossing the GenAI divide requires discipline. Organizations that succeed prioritize fewer initiatives, align technology with business needs, and rigorously evaluate progress. The insights that Andreas Welsch shared reinforce a consistent message. GenAI becomes valuable when organizations focus on outcomes, apply technology in context, and make deliberate decisions about where to invest and where to stop.
Leaders should review existing GenAI initiatives, identify which projects align with core business objectives, and reallocate resources toward efforts with measurable impact.
FAQ: Common Questions About Crossing the GenAI Divide
They connect technical capabilities with business problems and help leaders make informed investment decisions.
Cultural resistance and lack of governance make it difficult to stop initiatives once they begin.
By measuring progress against predefined business objectives rather than experimentation volume.
Clear goals, disciplined prioritization, and close collaboration between business and technology teams.
When it consistently fails to meet agreed-upon performance criteria.
Only a small number that demonstrate clear potential to influence key business outcomes